282 related articles for article (PubMed ID: 30582439)
41. Toxicological Aspects and Determination of the Main Components of Ayahuasca: A Critical Review.
Simão AY; Gonçalves J; Duarte AP; Barroso M; Cristóvão AC; Gallardo E
Medicines (Basel); 2019 Oct; 6(4):. PubMed ID: 31635364
[TBL] [Abstract][Full Text] [Related]
42. Dimethyltryptamine: Endogenous Role and Therapeutic Potential.
Rodrigues AV; Almeida FJ; Vieira-Coelho MA
J Psychoactive Drugs; 2019; 51(4):299-310. PubMed ID: 31018803
[TBL] [Abstract][Full Text] [Related]
43. Ayahuasca and the traveller: A scoping review of risks and possible benefits.
Houle SKD; Evans D; Carter CA; Schlagenhauf P
Travel Med Infect Dis; 2021; 44():102206. PubMed ID: 34785376
[TBL] [Abstract][Full Text] [Related]
44. Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges.
McKenna DJ
Pharmacol Ther; 2004 May; 102(2):111-29. PubMed ID: 15163593
[TBL] [Abstract][Full Text] [Related]
45. Quantitation of N,N-dimethyltryptamine and harmala alkaloids in human plasma after oral dosing with ayahuasca.
Callaway JC; Raymon LP; Hearn WL; McKenna DJ; Grob CS; Brito GS; Mash DC
J Anal Toxicol; 1996 Oct; 20(6):492-7. PubMed ID: 8889686
[TBL] [Abstract][Full Text] [Related]
46. Safety and side effects of ayahuasca in humans--an overview focusing on developmental toxicology.
dos Santos RG
J Psychoactive Drugs; 2013; 45(1):68-78. PubMed ID: 23662333
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans.
Valle M; Maqueda AE; Rabella M; Rodríguez-Pujadas A; Antonijoan RM; Romero S; Alonso JF; Mañanas MÀ; Barker S; Friedlander P; Feilding A; Riba J
Eur Neuropsychopharmacol; 2016 Jul; 26(7):1161-75. PubMed ID: 27039035
[TBL] [Abstract][Full Text] [Related]
48. Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking.
Kuypers KP; Riba J; de la Fuente Revenga M; Barker S; Theunissen EL; Ramaekers JG
Psychopharmacology (Berl); 2016 Sep; 233(18):3395-403. PubMed ID: 27435062
[TBL] [Abstract][Full Text] [Related]
49. Determination of N,N-dimethyltryptamine in beverages consumed in religious practices by headspace solid-phase microextraction followed by gas chromatography ion trap mass spectrometry.
Gaujac A; Dempster N; Navickiene S; Brandt SD; de Andrade JB
Talanta; 2013 Mar; 106():394-8. PubMed ID: 23598143
[TBL] [Abstract][Full Text] [Related]
50. Composition, standardization and chemical profiling of Banisteriopsis caapi, a plant for the treatment of neurodegenerative disorders relevant to Parkinson's disease.
Wang YH; Samoylenko V; Tekwani BL; Khan IA; Miller LS; Chaurasiya ND; Rahman MM; Tripathi LM; Khan SI; Joshi VC; Wigger FT; Muhammad I
J Ethnopharmacol; 2010 Apr; 128(3):662-71. PubMed ID: 20219660
[TBL] [Abstract][Full Text] [Related]
51. The alkaloids of Banisteriopsis caapi, the plant source of the Amazonian hallucinogen Ayahuasca, stimulate adult neurogenesis in vitro.
Morales-García JA; de la Fuente Revenga M; Alonso-Gil S; Rodríguez-Franco MI; Feilding A; Perez-Castillo A; Riba J
Sci Rep; 2017 Jul; 7(1):5309. PubMed ID: 28706205
[TBL] [Abstract][Full Text] [Related]
52. Ayahuasca and Dimethyltryptamine Adverse Events and Toxicity Analysis: A Systematic Thematic Review.
White E; Kennedy T; Ruffell S; Perkins D; Sarris J
Int J Toxicol; 2024; 43(3):327-339. PubMed ID: 38363085
[TBL] [Abstract][Full Text] [Related]
53. Ayahuasca: Uses, Phytochemical and Biological Activities.
Estrella-Parra EA; Almanza-Pérez JC; Alarcón-Aguilar FJ
Nat Prod Bioprospect; 2019 Aug; 9(4):251-265. PubMed ID: 31134518
[TBL] [Abstract][Full Text] [Related]
54. Effects of the South American psychoactive beverage ayahuasca on regional brain electrical activity in humans: a functional neuroimaging study using low-resolution electromagnetic tomography.
Riba J; Anderer P; Jané F; Saletu B; Barbanoj MJ
Neuropsychobiology; 2004; 50(1):89-101. PubMed ID: 15179026
[TBL] [Abstract][Full Text] [Related]
55. [Ayahuasca in the Netherlands: what the doctor should know about its side effects].
van den Berg A; van Eeghen EE; Kooter AJ; Tuinman TH; Tuinman PR
Ned Tijdschr Geneeskd; 2020 Aug; 164():. PubMed ID: 32940978
[TBL] [Abstract][Full Text] [Related]
56. Light microscopy can reveal the consumption of a mixture of psychotropic plant and fungal material in suspicious death.
Wiltshire PE; Hawksworth DL; Edwards KJ
J Forensic Leg Med; 2015 Aug; 34():73-80. PubMed ID: 26165663
[TBL] [Abstract][Full Text] [Related]
57. Molecular Pathways of the Therapeutic Effects of Ayahuasca, a Botanical Psychedelic and Potential Rapid-Acting Antidepressant.
Rossi GN; Guerra LTL; Baker GB; Dursun SM; Saiz JCB; Hallak JEC; Dos Santos RG
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358968
[TBL] [Abstract][Full Text] [Related]
58. The pharmacological interaction of compounds in ayahuasca: a systematic review.
Ruffell S; Netzband N; Bird C; Young AH; Juruena MF
Braz J Psychiatry; 2020; 42(6):646-656. PubMed ID: 32638916
[TBL] [Abstract][Full Text] [Related]
59. An ontogenic study of the behavioral effects of chronic intermittent exposure to ayahuasca in mice.
Correa-Netto NF; Masukawa MY; Nishide F; Galfano GS; Tamura F; Shimizo MK; Marcato MP; Santos JG; Linardi A
Braz J Med Biol Res; 2017 Jun; 50(7):e6036. PubMed ID: 28591379
[TBL] [Abstract][Full Text] [Related]
60. A placebo-controlled study of the effects of ayahuasca, set and setting on mental health of participants in ayahuasca group retreats.
Uthaug MV; Mason NL; Toennes SW; Reckweg JT; de Sousa Fernandes Perna EB; Kuypers KPC; van Oorsouw K; Riba J; Ramaekers JG
Psychopharmacology (Berl); 2021 Jul; 238(7):1899-1910. PubMed ID: 33694031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
